Nautilus Biotechnology Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | +328.1% | +21.1% | +20.2% | +67.0% | +11.4% | +1.8% | |
| – | – | +235.5% | +2,050.1% | +30.8% | +16.9% | +4.6% | -46.1% | |
| – | – | – | +1,115.5% | +28.6% | – | – | – | |
| – | -141.1% | – | – | – | – | – | – | |
| – | – | -0.5% | +146.4% | +2.4% | +5.1% | -13.1% | -39.8% | |
| – | +238.0% | -724.2% | +449.7% | -81.5% | +69.9% | – | -46.8% | |
| – | – | – | – | – | – | – | – | |
| – | -27.0% | – | -105.2% | – | +13.8% | +98.5% | -70.2% | |
| – | -100.0% | +210,730.6% | +331.4% | -99.8% | -34.5% | +210.9% | -81.3% | |
| – | -50.3% | +6,055.3% | +307.5% | -147.6% | – | – | -285.0% | |
| – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.